2019 2018 2017 2016 2015 2014 2013 2012 2011 2010以前

in press


8.Majima R., Koshizuka T., Inoue N.
The guinea pig cytomegalovirus GP119.1 gene encodes an IgG-binding glycoprotein that is incorporated into the virion. Microbiol. Immunol. 08 December 2020  doi: 10.1111/1348-0421.12867

7. Kanno R, Koshizuka T, Miyazaki N, Kobayashi T, Ishioka K, Ozaki C, Chiba H, Suzutani T.
Protection of Fatty Liver by the Intake of Fermented Soybean Paste, Miso, and Its Pre-Fermented Mixture. Foods, 2021. 10(2), 291. doi: https://doi.org/10.3390/foods10020291

6.Minegaki N, Koshizuka T, Nishina S, Kondo H, Takahashi K, Sugiyama T, Inoue N.
The carboxyl-terminal penta-peptide repeats of major royal jelly protein 3 enhance cell proliferation. Biol. Pharm. Bull.  2020;43(12):1911-1916. doi: 10.1248/bpb.b20-00607

5.Kazuma Noguchi, Ryuichi Majima, Keita Takahashi, Yoshihiko Iwase, Souichi Yamada, Keisuke Satoh, Tetsuo Koshizuka, Naoki Inoue.
Identification and functional analyses of a cell-death inhibitor encoded by guinea pig cytomegalovirus gp38.1 in cell culture and in animals. J. Gen. Virol. 2020 Sep;101(12):1270-1279,  doi:  https://doi.org/10.1099/jgv.0.001493

4.Koshizuka T, Inoue N.
Activation of c-Jun by human cytomegalovirus UL42 through JNK activation.
PLoS One. 2020 May;15(5):e0232635. doi: 10.1371/journal.pone.0232635.

3.Okumura M, Matsuura-Miura M, Makino R, Miura T, Noguchi K, Majima R, Koshizuka T, Inoue N.
Enhancement of guinea pig cytomegalovirus infection by two endogenously expressed components of the pentameric glycoprotein complex in epithelial cells. Scientific Reports, 2020 May ; 10: 8530 (2020) doi: 10.1038/s41598-020-65545-5

2.Takahashi K, Orito N, Yanagisawa D, Yano A, Mori Y, Inoue N.
Eosinophils are the main cellular targets for oral gene delivery using Lactic acid bacteria. Vaccine, 2020 Mar ; 38:3330-3338,   doi:10.1016/j.vaccine.2020.02.084

1.Raymund R.Raxonable,Naoki Inoue,Swetha G.Pinninti,Suresh B.Boppana,Tiziana Lazzatotto,Liliana Gabrielli,Giuliana Simonazzi,Philip E,Pellett,and D.Scott Schmid.
Clinical Diagnostic Testing for Human Cytomegalovirus Infections.
J.Infect.Dis 2020 Mar  ;221(S1);S74-85,doi:10.1093/infdis/jiz601.


4.Kotani H, Koshizuka T, Matsubara K, Nishiyama K, Sugiyama T, Suzutani T.
Relationship between Human β-defensin 2 and the vaginal environment.
Jpn J Infect Dis. 2019 Dec . doi: 10.7883/yoken.JJID.2019.190.

3.Takahashi K, Orito N, Tokunoh N, Inoue N.
Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers. Applied Microbiology and Biotechnology. 2019 Aug; 103(15):5947-5955. doi: 10.1007/s00253-019-09912-x.

2.Ikuta K, Koshizuka T, Kanno R, Inoue N, Kubo T, Koyano S, Suzutani T.
Evaluation of the indirect and IgM-capture anti-human cytomegalovirus (CMV) IgM ELISA methods as confirmed by CMV IgG avidity. Microbiol Immunol. 2019 Apr ; 63(5):172-178. doi: 10.1111/1348-0421.12683.

1.Takahashi K,  Hanamura Y,  Tokunoh N,  Kassai K, Matsunishi M,  Watanabe S, Sugiyama T, Inoue N.
Protective effects of oral immunization with formalin-inactivated whole-cell Citrobacter rodentium on Citrobacter rodentium infection in mice. Journal of Microbiological Methods. 2019 Apr; 159:62–68. doi:10.1016/j.mimet.2019.02.016 .



16.Kotani H, Matsubara K, Koshizuka T, Nishiyama K, Kaneko H, Tasaka M,Sugiyama T, Suzutani T.
Human β-defensin 2 as a biochemical indicator of vaginal environment in pregnant woman.Hypertension Reserch in Pregnancy. 2018,6:68-72 doi: 10.14390/jsshp.HRP2018-005

15.Koshizuka T, Matsuda Y, Suzuki H, Kanno R, Ikuta K, Kobayashi T, Kondo T, Okada Y, Suzutani T.
Detection of engraftment of donor-derived antibody producing cells in a lung transplant recipient by anti-cytomegalovirus IgG avidity test.Transplant Immunol, 2019 Apr; 53:34-37. doi: 10.1016/j.trim.2018.12.003.

14.Takeda M,  Watanabe S,  Katano H,  Noguchi K, Sato Y,  Kojima S, Miura T,  Majima R,  Yamada S, Inoue N.
Roles of GP33, a guinea pig cytomegalovirus-encoded G protein-coupled receptor homolog, in cellular signaling, viral growth and inflammation in vitro and in vivo.  PLoS Pathogens. 2018 Dec  ;14(12): e1007487. doi:10.1371/journal.ppat.1007487.

13.Nishiyama K, Kobayashi T, Sato Y, Watanabe Y, Kikuchi R, Kanno R, Koshizuka T, Miyazaki N, Ishioka K, Suzutani T.
A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with Lactococcus lactis 11/19-B1 and Bifidobacterium lactis on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-γ Releasing Ability. Nutrients. 2018 Nov ;10(11). pii: E1778. doi: 10.3390/nu10111778.

12.Koshizuka T, Toriyabe K, Sato Y, Ikuta K, Ikeda T, Suzutani T.
Congenital cytomegalovirus infection via a re-infected mother with original antigenic sin: A case report. Int J Infect Dis. 2018 Oct ;77:87-89.doi: 10.1016/j.ijid.2018.10.006.

11.Takahashi K, Yano A,  Watanabe S, Philippe Langella, Luis G. Bermúdez-Humarán, Inoue N.
M-cell targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.Applied Microbiology and Biotechnology. 2018 Dec ;102(24):10703-10711. doi:10.1007/s00253-018-9427-1

10.Koshizuka T, Sato Y, Kobiyama S, Oshima M, Suzutani T.
A two-step culture method utilizing secreted luciferase recombinant virus for the detection of anti-cytomegalovirus compounds. Micorbiol. Immunol. 2018 Oct;62(10):651-658. doi: 10.1111/1348-0421.12645

9.Kobayashi R, Abe M, Oguri K, Torikai M, Nishimura T, Mori H, Koshizuka T, Inoue N.
Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates. Vaccine. 2018 Sep; 36(40):5983-5989. doi:10.1016/j.vaccine.2018.08.054

8.Miura T, Makino R, Yamada K, Matsuura M, Okumura M, Yamada S, Watanabe S, Inoue N.
Differences in the effects of mutations in GP131, a guinea pig cytomegalovirus homologue of pentameric complex component UL130, on macrophage and epithelial cell infection.  J Gen Virol.  2018 Aug; 99(10):1425-1431 doi: 10.1099/jgv.0.001137

7.Tahara K, Kobayashi M, Yoshida S, Onodera R, Inoue N, Takeuchi H.
Effects of cationic liposomes with stearylamine against virus infection Int J Pharm 543:311-7, 2018. doi: 10.1016/j.ijpharm.2018.04.001

6.Yamada K, Majima R, Yamaguchi T, Inoue N. 
Characterization of phenyl pyrimidine derivatives that inhibit cytomegalovirus immediate-early gene expression. Antivir Chem Chemother 26:1-7, 2018.  doi: 10.1177/2040206618763193  http://journals.sagepub.com/doi/pdf/10.1177/2040206618763193

5.Yano A, Takahashi K, Mori Y, Watanabe S, Hanamura Y, Sugiyama T, Inoue N.
Peyer’s patches as a portal for DNA delivery by Lactococcus lactis in vivo. Biol Pharm Bull, 41:1-9, 2018.  doi: 10.1248/bpb.b17-00657 https://www.jstage.jst.go.jp/article/bpb/41/2/41_b17-00657/_pdf/-char/en

4.Koyano S, Morioka I, Oka A, Moriuchi H, Asano K, Ito Y, Yoshikawa T, Yamada H, Suzutani T, Inoue N for the Japanese Congenital Cytomegalovirus Study Group.
More than two years follow-up of infants with congenital cytomegalovirus infection in Japan. Pediatr Int, 60:57-62, 2018. doi: 10.1111/ped.13433http://onlinelibrary.wiley.com/doi/10.1111/ped.13433/pdf

3.Koshizuka TKobayashi T, Ishioka K, Suzutani T.
Herpesviruses possess conserved proteins for interaction with Nedd4 family ubiquitin E3 ligases.   Sci. Rep. 2018 volume 8, Article number: 4447

2.Xiaojie Li,Xiaoxia  Li, Wei Gong, Guanqing Wang, Zhenling Lu, Ningjun Wu, Chengxiang Lian, Ling Huang, Naoki Inoue.
Titration of cell-associated varicella-zoster virus with the MV9G reporter cell line for antiviral studies. J Virol Methods 260:14-20, 2018. doi:10.1016/j.jviromet.2018.06.019

1.Inoue N, Abe M, Kobayashi R, Yamada S.
Vaccine development for cytomegalovirus. In: Kawaguchi Y., Mori Y., Kimura H.
(eds) Human Herpesviruses. Adv Exp Med Biol. 1045:271-296, 2018. doi:10.1007/978-981-10-7230-7_13



6.Yasui R, Yoshida C, Yamaguchi T, Inoue N.
Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54.  Micribiology and Immunology 61:398-402,2017.

5.Fujii T, Oka A, Morioka I, Moriuchi H, Koyano S, Yamada H, Saito S, Sameshima H, Nagamatsu K, Tsuchida S, Inoue N for the Japanese Congenital Cytomegalovirus Study Group.  Newborn congenital cytomegalovirus screening based on clinical manifestations and evaluation of DNA-based assays for in vitro diagnostics.Ped Infec Dis J 36:942-946, 2017.
doi: 10.1097/INF.0000000000001630

4.Ryuichi Majima,Keiko Shindoh,Toyofumi Yamaguchi,and Naoki Inoue.
Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62. Antiviral Research 140(2017):142-150 (impact factor4.9)  doi: 10.1016/j.antiviral.2017.01.024

3.Minoura K, Yamada M, Mizoguchi T, Kaneko T, Nishiyama K, Ozminskyj M, Koshizuka T, Suzutani T.
Antibacterial Effect of Artificial Surface of Nanoimprinted Moth-eye Film.
PLoS One 2017 Sep 21;12(9):e0185366. DOI: 10.1371/journal.pone.0185366

2.Kobayashi T, Sato JI, Ikuta K, Kanno R, Nishiyama K, Koshizuka T, Ishioka K, Suzutani T.
Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.
Fukushima J Med Sci. 2017 Aug 9;63(2):64-74.  doi: 10.5387/fms.2017-01

1.Sato Y, Koshizuka T, Ishibashi K, Hashimoto K, Ishioka K, Ikuta K, Yokota S, Fujii N, Suzutani T.
Involvement of herpes simplex virus type 1 UL13 protein kinase in the induction of SOCS genes, the negative regulator of cytokine signaling.
Microbiol Immunol. 2017 May;61(5):159-167.  doi: 10.1111/1348-0421.12483



4.Nishida K, Morioka I, Nakamachi Y, Kobayashi Y, Imanishi T, Kawano S, Iwatani S, Koda T, Deguchi M, Tanimura K, Yamashita D, Nibu KI, Funakoshi T, Ohashi M, Inoue N, Iijima K, Yamada H. Neurological outcomes in congenital symptomatic cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment.
Brain & Dev 38:209-16, 2016.

3.Yamada S, Katano H, Sato Y, Fukuchi S, Hashimoto K, Inoue N.  An Ex vivo culture model for placental cytomegalovirus infection using slices of guinea pig placental tissue.  Placenta 37:85-8,2016

2.Koshizuka T, Ishioka K, Kobayashi T, Ikuta K, Suzutani T.
Protection from lethal herpes simplex virus type 1 infection by vaccination with a UL41-deficient recombinant strain.
Fukushima J Med Sci. 2016 Jun 8;62(1):36-42.  doi: 10.5387/fms.2015-24

1.Koshizuka T, Tanaka K, Suzuani T.
Degradation of host ubiquitin E3 ligase Itch by human cytomegalovirus UL42.
J. Gen. Virol. 2016 Jan;97: 196-208.  doi: 10.1099/jgv.0.000336



4.Taniguchi R, Koyano S, Suzutani T, Goishi K, Ito Y, Morioka I, Nakamura H, Yamada H, Oka A, Inoue N*.  A Thr72Ala polymorphism in the NKG2D gene is associated with early symptomatic congenital cytomegalovirus disease.  Infection 43:353-9, 2015.

3.井上直樹 先天性サイトメガロウイルス感染症の実態と予防・治療の方向性    岐阜薬科大学紀要64: 1-10 , 2015.

2.Kobayashi Y, Morioka I, Koda T, Nakamachi Y, Okazaki Y, Noguchi Y, Ogi M, Chikahira M, Tanimura K, Ebina Y, Funakoshi T, Ohashi M, Iijima K, Inoue N, Kawano S, Yamada H. Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection. J Perinatal Med 43: 239-243, 2015. www.degruyter.com/view/j/jpme.2015.43.issue-2/jpm-2014-0071/jpm-2014-0071.xml

1.Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S, Suda W, Imaoka A, Setoyama H, Nagamori T, Ishikawa E, Shima T, Hara T, Kado S, Jinnohara T, Ohno H, Kondo T, Toyooka K, Watanabe E, Yokoyama SI, Tokoro S, Mori H, Noguchi Y, Morita H, Ivanov II, Sugiyama T, Nuñez G, Camp JG, Hattori M, Umesaki Y, Honda K.  Th17 cell induction by adhesion of microbes to intestinal epithelial cells.  Cell 163: 367-380, 2015 www.sciencedirect.com/science/article/pii/S0092867415011101



12.Yamada S, Fukuchi S, Hashimoto K, Fukui Y, Tsuda M, Kataoka M, Katano H, Inoue N*. Guinea pig cytomegalovirus GP129/131/133, homologs of human cytomegalovirus UL128/130/131A, are required for viral entry into monocytes and macrophages. J Gen Virol 95: 1376-1382, 2014.  vir.sgmjournals.org/content/95/Pt_6/1376.abstract?sid=dd27ab25-4d76-44c7-af80-05c889469eba

11.Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara T, Shimizu N, Kurahashi H, Yoshikawa T, Katano H, Inoue N, Imai K, Takagi M, Morio T, Mizutani S. Reactivation from Chromosomally Integrated HHV-6.  Clin Infec Dis 59: 545-548, 2014.  cid.oxfordjournals.org/content/59/4/545.abstract

10.Ebina Y, Minematsu T, Sonoyama A, Morioka I, Inoue N, Tairaku S, Nagamata S, Tanimura K, Morizane M, Deguchi M, Yamada H. The IgG avidity value for the prediction of congenital cytomegalovirus infection in a prospective cohort study. J Perinatal Med 42: 755-759, 2014. www.degruyter.com/view/j/jpme.2014.42.issue-6/jpm-2013-0333/jpm-2013-0333.xml;jsessionid=516933B5B6012D78956EEBE3A752D8BE

9.Pereira L, Petitt M, Fong A, Tsuge M, Tabata T, Fang-Hoover J, Maidji E, Zydek M, Zhou Y, Inoue N, Logahvi S, Pepkowitz S, Ogunyemi D. Idiopathic intrauterine growth restriction caused by cytomegalovirus infection and associated placental pathology. J Infec Dis 209: 1573-1584, 2014.  www.jid.oxfordjournals.org/content/209/10/1573.long

8.Ishibashi K, Tokumoto T, Shirakawa H, Oguro T, Yanagida T, Takahashi N, Nomiya M, Haga N, Aikawa K, Tanabe K, Inoue N, Kojima Y, Suzutani T. The presence of antibodies against the AD2 epitope of cytomegalovirus glycoprotein B is associated with acute rejection after renal transplantation. Microbiol Immunol 58: 72-75, 2014.  onlinelibrary.wiley.com/doi/10.1111/1348-0421.12112/abstract;jsessionid=A8752F58FE10DACE964F509487CC8FE9.f02t03

7.Kakuta R, Okata U, Funakoshi T, Fujio Y, Inoue N, Takahashi S, Amagai M, Ohyama M. Unusually extensive disseminated herpes zoster with multiple ulcer formation in a methotrexate-treated rheumatoid arthritis patient. J Dermatol 41: 181-182, 2014. onlinelibrary.wiley.com/doi/10.1111/1346-8138.12377/abstract

6.Liao H, Lee J-H, Kondo R, Katata M, Imadome K, Miyado K, Inoue N, Fujiwara S, Nakamura H. The highly conserved HCMV UL136 ORF encodes multiple protein isoforms localizing in the Golgi apparatus. Virus Res 179: 241-246, 2014. www.sciencedirect.com/science/article/pii/S0168170213003924

5.Matsuo K, Morioka I, Oda M, Kobayashi Y, Nakamachi Y, Kawano S, Nagasaka M, Koda T, Yokota T, Morikawa S, Miwa A, Shibata A, Minematsu T, Inoue N, Sugimura K, Yamada H, Iijima K. Quantitative evaluation of ventricular dilatation using computed tomography in infants with congenital cytomegalovirus infection. Brain & Dev 36: 10-15, 2014. www.sciencedirect.com/science/article/pii/S0387760412003257

4.Sakao-Suzuki M, Kawasaki H, Akamatsu T, Meguro S, Miyajima H, Iwashita T, Tsutsui Y, Inoue N, Kosughi I. Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection. Ann Clin Transl Neurol 1: 570-88,2014.  www.ncbi.nlm.nih.gov/pmc/articles/PMC4184560/pdf/acn30001-0570.pdf

3.Mine S, Suzuki K, Sato Y, Fukumoto H, Kataoka M, Inoue N, Ohbayashi C, Hasegawa H, Sata T, Fukayama M,Katano H.  Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: A case report.  J Clin Virol 61: 448-452, 2014. www.sciencedirect.com/science/article/pii/S1386653214003424

2.Sato K, Sugiyama T, Nagase T, Kitade Y, Ueda H. Threonine 680 phosphorylation of FLJ00018/PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by epidermal growth factor receptor signaling regulates cell morphology of Neuro-2a cells.J Biol Chem 289: 10045-56, 2014. www.jbc.org/content/289/14/10045.long

1.Nagano K, Taguchi K, Tokoro S, Tatsuno I, Mori H. Adhesion of enterohemorrhagic Escherichia coli O157:H7 to the intestinal epithelia is essential for inducing secretory IgA antibody production in the intestine of mice.  Biol Pharm Bull 37: 409-16, 2014. www.jstage.jst.go.jp/article/bpb/37/3/37_b13-00763/_article



11.Nakamichi K, Inoue N, Shimokawa T, Kurane I, Lim C-K, Saijo M. Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy.  BMC Neurolog 13: 200, 2013. biomedcentral.com/1471-2377/13/200

10.Taniguchi R, Koyano S, Suzutani T, Goishi K, Ito Y, Morioka I, Oka A, Nakamura H, Yamada H, Igarashi T, Inoue N*. Polymorphisms in Toll-like receptor 2 are associated with congenital cytomegalovirus infection. Int J Infec Dis 17: e1092-7, 2013. sciencedirect.com/science/article/pii/S1201971213002166

9.Nakamura H, Liao H, Minami K, Toyoda M, Akutsu H, Miyagawa Y, Okita H, Kiyokawa N, Umezawa A, Imadome K, Inoue N, Fujiwara S. Human cytomegalovirus induces apoptosis in neural stem/progenitor cells derived from induced pluripotent stem cells by generating mitochondrial dysfunction and endoplasmic reticulum stress. Herpesviridae 4: 2, 2013. www.herpesviridae.org/content/4/1/2

8.Ikuta K, Minematsu T, Inoue N, Kubo T, Asano K, Ishibashi K, Imamura T, Nakai H, Yoshikawa T, Moriuchi H, Fujiwara S, Koyano S, Suzutani Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers. J Clin Virol 58: 474-478, 2013. www.sciencedirect.com/science/article/pii/S1386653213002795

7.Hashimoto K, Yamada S, Katano H, Fukuchi S, Sato Y, Kato M, Yamaguchi T, Moriishi K, Inoue N*. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta.  Vaccine 31: 3199-205, 2013. www.sciencedirect.com/science/article/pii/S0264410X13005513

6.Koyano S, Inoue N, Nagamori T, Moriuchi H, Azuma H. Newborn screening of congenital cytomegalovirus infection using saliva can be influenced by breast feeding. Arch Dis Child Fetal 98: F182, 2013fn.bmj.com/content/98/2/F182.1.extract

5.Kakiuchi S, Nonoyama S,Wakamatsu H, Kogawa K, Wang L, Kinoshita-Yamaguchi H, Takayama-Ito M, Lim C-K, Inoue N, Mizuguchi M, Igarashi T, Saijo M. Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant HSV-1. J Clin Microbiol 51: 356-359, 2013.  jcm.asm.org/content/51/1/356.long

4.Komatsu T, Kido N, Sugiyama T, Yokochi T. Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection. Immunopharmacol Immunotoxicol 35: 1-7, 2013. informahealthcare.com/doi/abs/10.3109/08923973.2012.710636

3.Sato K, Handa H, Kimura M, Okano Y, Nagaoka H, Nagase T, Sugiyama T, Kitade Y, Ueda H. Identification of a Rho family specific guanine nucleotide exchange factor, FLJ00018, as a novel actin-binding protein. Cell Signal 25: 41-49, 2013. sciencedirect.com/science/article/pii/S0898656812002574

2.Sugiyama T*, Takahashi K, Kuzumaki A, Tokoro S, Neri P, Mori H. Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-β-induced nitric oxide production. Inflammation 36: 372-378, 2013.  link.springer.com/article/10.1007%2Fs10753-012-9556-0

1.Takahashi K, Sugiyama T*, Tokoro S, Neri P, Mori H. Inhibitory effect of 10-hydroxydecanoic acid on lipopolysaccharide-induced nitric oxide production via translational downregulation of interferon regulatory factor-1 in RAW264 murine macrophages. Biomed Res 34: 205-214, 2013. jstage.jst.go.jp/article/biomedres/34/4/34_205/_article



9.Inoue N*, Matsushita M, Fukui Y, Yamada S, Tsuda M, Higashi C, Kaneko K, Hasegawa H, Yamaguchi T. Identification of an antiviral compound that targets the varicella-zoster virus major capsid protein (ORF40) and inhibits the normal capsid maturation. J Virol 86: 12198-12207, 2012.  jvi.asm.org/cgi/pmidlookup?view=long&pmid=22933294

8.Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S, Inoue N, Pereira L. Cytomegalovirus impairs CTB-induced lymph-angiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol 181: 1540-1559, 2012. www.ncbi.nlm.nih.gov/pmc/articles/PMC3483806/

7.Sonoyama A, Ebina Y, Morioka I, Tanimura K, Morizane M, Tairaku S, Minematsu T, Inoue N, Yamda H. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection. J Med Virol 84: 1928-1933, 2012. onlinelibrary.wiley.com/doi/10.1002/jmv.23387/abstract

6.Ikuta K, Ishioka K, Sato Y, Imamura T, Asano K, Koyano S, Inoue N, Suzutani T. A novel real-time PCR method for the determination and quantification of each cytomegalovirus (CMV) gH-subtype in clinical  J Clin Microbiol 50: 499-501, 2012. jcm.asm.org/cgi/pmidlookup?view=long&pmid=22116147

5.Matsui T, Ogawa H, Yamada N, Baba Y, Suzuki Y, Nomoto M, Suzutani T, Inoue N, Omori K. Outcome of cochlear implantation in children with congenital cytomegalovirus infection or GJB2 mutation. Acta Oto-Laryngologica 132: 597-602, 2012. informahealthcare.com/doi/abs/10.3109/00016489.2011.653445

4.Sugiyama T*, Gotou T, Moriyama K, Kajiura N, Hasegawa T, Tomida J, Takahashi K,
Komatsu T, Ueda H, Sato K, Tokoro S, Neri P, Mori H. Mechanism of inhibition of
lipopolysaccharide-induced interferon-β production by 2-aminopurine. Mol Immunol
52: 299-304, 2012. www.sciencedirect.com/science/article/pii/S0161589012003306

3.Neri P, Tokoro S, Sugiyama T, Umeda K, Shimizu T, Tsuji T, Kodama Y, Mori H.
Recombinant Shiga toxin B subunit can induce neutralizing immunoglobulin Y
antibody. Biol Pharm Bull 35: 917-923, 2012. www.jstage.jst.go.jp/article/bpb/35/6/35_b12-00008/_article

2.Takahashi K, Sugiyama T*, Tokoro S, Neri P, Mori H.  Inhibition of
interferon-γ-induced nitric oxide production by 10-hydroxy-trans-2-decenoic acid
through inhibition of interferon regulatory factor-8 induction. Cell Immunol 273: 73-78, 2012. www.sciencedirect.com/science/article/pii/S000887491100298X

1.Sugiyama T*, Takahashi K, Tokoro S, Gotou T, Neri P, Mori H. Inhibitory effect
of 10-hydroxy-trans-2-decenoic acid on LPS-induced IL-6 production via reducing
IκB-ζ expression. Innate Immun. 18: 429-37, 2012. www.ncbi.nlm.nih.gov/pubmed/21948282



7.Koyano S, Inoue N*, Oka A, Moriuchi H, Asano K, Ito Y, Yamada H, Yoshikawa T, Suzutani T, for the Japanese Congenital Cytomegalovirus Study Group. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multi-centre study. BMJ Open 1:e000118, 2011.  bmjopen.bmj.com/content/1/1/e000118.long

6.Kanai K, Yamada S, Yamamoto Y, Fukui Y, Kurane I, Inoue N*. Re-evaluation of guinea pig cytomegalovirus complete genome sequence. J Gen Virol 92: 1005-1020, 2011. vir.sgmjournals.org/content/92/5/1005.long

5.Kashiwagi Y, Nakajima J, Ishida Y, Nishimata S, Kawashima H, Miyajima T, Takekuma K, Hoshika A, Inoue N. Prolonged valganciclovir therapy for congenital cytomegalovirus infection. J Infect Chemo 17: 538- 540, 2011.

4.Imamura T, Suzutani T, Ogawa H, Asano K, Momoi N, Ikuta K, Inoue N, Hosoya M. Oral valganciclovir treatment for congenital cytomegalovirus infection in a five month old girl with progressive hearing loss. Pediatr Int 53:249-252, 2011. onlinelibrary.wiley.com/doi/10.1111/j.1442-200X.2010.03217.x/abstract;jsessionid=82BBB5BC6EC124580E60671285FF9D7F.f03t04

3.Ishibashi K, Tokumoto T, Shirakawa H, Hashimoto K, Ikuta K, Kushida N, Yanagida T, Shishido K, Aikawa K, Toma H, Inoue N, Yamaguchi O, Tanabe K, Suzutani T. The lack of antibodies against the AD2 epitope of cytomegalovirus (CMV) glycoprotein B (gB) is associated with CMV disease after renal transplantation in recipients having gH serotypes same as their donors. Transplant Infect Dis 13: 318- 328, 2011. onlinelibrary.wiley.com/doi/10.1111/j.1399-3062.2010.00563.x/abstract

2.Folster JM, Jensen NJ, Ruyechan WT, Inoue N, Schmid DS. Regulation of the expression of the varicella-zoster virus open reading frame 66 gene. Virus Res 155: 334-342, 2011. www.sciencedirect.com/science/article/pii/S0168170210003928

1.Neri P, Tokoro S, Kobayashi R, Sugiyama T, Umeda K, Shimizu T, Tsuji T, Kodama Y, Oguma K, Mori H.
Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases. PLoS One 6: e26526, 2011. www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026526